Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Charles River Laboratories

Close the acquisition of Cognate BioServices

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
17 Feb 2021
Due
31 Mar 2021
Delivered
29 Mar 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“The transaction is expected to close by the end of the first quarter of 2021, subject to regulatory requirements and customary closing conditions.”

What we found

Evidence strength A What the grades mean

The company's later 10-Q filings state it acquired Cognate BioServices on March 29, 2021, before the end-of-Q1 2021 deadline.

  • A
    Charles River Laboratories 10-Q filed 2021-05-04 Regulatory filing · published 4 May 2021 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint 0fad089ca98f
    “On March 29, 2021 (second fiscal quarter of 2021), the Company acquired Cognate BioServices, Inc. (Cognate BioServices) for approximately $875 million in cash, subject to customary closing adjustments.” ✓ confirmed on the page
  • A
    Charles River Laboratories 10-Q filed 2021-08-04 Regulatory filing · published 4 Aug 2021 · retrieved 10 Oct 2026 · kept permanently by the SEC · fingerprint e0fc72c4219d
    “Beginning on March 29, 2021, Cognate has been included in the operating results of the Company.” ✓ confirmed on the page

Market reaction: the shares moved +1.3% against the S&P 500 over the three sessions around the disclosure (3 May 2021 to 6 May 2021). What this measures

Checked 10 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Acquisition close
Indicative materiality
High rules
Action
Close
Deliverable
Acquisition of Cognate BioServices
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High
Conditional
Yes: subject to regulatory requirements; customary closing conditions
Depends on
Regulatory

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Charles River Laboratories? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-CRL-005517 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.